GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q4 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $198.6 million versus the consensus estimate of $199.76 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q1 2025 revenue of $201-205 million, versus the consensus of $202.6 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.